Current report 24/2021– The Management Board’s recommendation on the distribution of profit for the year 2020
Date prepared: 05/31/2021, 2:19 pm
Subject: The Management Board’s recommendation on the distribution of profit for the year 2020.
Legal basis: Article 17 section 1 of the Market Abuse Regulation (MAR) – confidential information.
Management Board of Celon Pharma S.A. (the “Company”) informs that on May 31, 2021 it made a decision to recommend the Ordinary General Meeting to allocate the earned net profit for the year 2020 amounting to PLN 21,494,827.07 in the following manner:
a) PLN 18,344,827.07 is to be allocated to the Company’s reserve Capital,
b) PLN 3,150,000.00 is to be paid out to shareholders as dividend, i.e. PLN 0.07 per share.
The Management Board recommends June 12, 2021 as the dividend record date and recommends that the dividend be paid out on August 05, 2021.
The Management Board is of the opinion that payment of the dividend in the above-mentioned amount is justified by the financial assets of the Company held as at the date of adopting the resolution, and at the same time allows the Company to finance its further development.